Big Pharma strikes back with data secrecy [Off Topic]

posted by mittyri – Russia, 2019-10-28 11:13 (1248 d 07:01 ago) – Posting: # 20727
Views: 3,402
(edited by mittyri on 2019-10-28 12:59)

Hi all,

Some EMA news

If the Court of Justice upholds the view that CSRs [clinical study reports] should benefit from a general presumption of confidentiality, it would change the rules of the game. Sadly, such a move could easily take us back to a situation where disclosure of clinical trial data is the exception, instead of being the norm.

See here
—
Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
22,557 posts in 4,724 threads, 1,607 registered users;
27 visitors (0 registered, 27 guests [including 12 identified bots]).
Forum time: 19:14 CEST (Europe/Vienna)

The function of genius is not to give new answers, but to pose
new questions which time and mediocrity can resolve.    H.R. Trevor-Roper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5